Blood or Urine IP-10 cannot discriminate between active tuberculosis and respiratory diseases different from tuberculosis in children

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Petrone, Linda ^a   Cannas, Angela ^a   Aloi, Francesco ^b   Nsubuga, Martin ^b   Sserumkuma, Joseph ^b   Nazziwa, Ritah Angella ^b   Jugheli, Levan ^c,d,e   Lukindo, Tedson ^e   Girardi, Enrico ^a   Reither, Klaus ^c,d,e   Goletti, Delia ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b Italian Association for Solidarity among People ^*  (Uganda)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^d UNIVERSITY OF BASEL   (Switzerland)

^e IFAKARA HEALTH INSTITUTE   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; NITRIC ACID DERIVATIVE; CXCL10 PROTEIN, HUMAN;

ACCURACY; ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; KIDNEY FUNCTION; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS TEST KIT; PH; PNEUMONIA; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; PROTEINURIA; RELATIVE DENSITY; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS; ADULT; BLOOD; CLINICAL TRIAL; INFANT; MULTICENTER STUDY; PREDICTIVE VALUE; PRESCHOOL CHILD; TUBERCULOSIS, PULMONARY; UGANDA; URINE;

ADOLESCENT; ADULT; CHEMOKINE CXCL10; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TUBERCULOSIS, PULMONARY; UGANDA;

EID: 84939506370     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/589471     Document Type: Article

References (31)

1. WHO, "Global tuberculosis report 2014," WHO Global TB Report 2014, 2014.
2. D. Portevin, F. Moukambi, P. Clowes et al. , "Assessment of the novel T-cell activation marker-tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-ofconcept study," The Lancet Infectious Diseases, vol. 14, no. 10, pp. 931-938, 2014.
3. H. J. Zar, T. G. Connell, and M. Nicol, "Diagnosis of pulmonary tuberculosis in children: new advances," Expert Review of Anti-InfectiveTherapy, vol. 8, no. 3, pp. 277-288, 2010.
4. L. E. Cuevas, R. Browning, P. Bossuyt et al. , "Evaluation of tuberculosis diagnostics in children: 2. Methodological issues for conducting and reporting research evaluations of tuberculosis diagnostics for intrathoracic tuberculosis in children. Consensus from an expert panel," The Journal of Infectious Diseases, vol. 205, supplement 2, pp. S209-S215, 2012.
5. E. Berti, L. Galli, E. Venturini, M. deMartini, and E. Chiappini, "Tuberculosis in childhood: a systematic review of national and international guidelines," BMC Infectious Diseases, vol. 14, supplement 1, article S3, 2014.
6. National Institute for Health and Care Excellence, Clinical Diagnosis andManagement of Tuberculosis, andMeasures for Its Prevention and Control, 2011.
7. J. R. Groom and A. D. Luster, "CXCR3 ligands: redundant, collaborative and antagonistic functions," Immunology and Cell Biology, vol. 89, no. 2, pp. 207-215, 2011.
8. A. Sauty, M. Dziejman, R. A. Taha et al. , "The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells," The Journal of Immunology, vol. 162, no. 6, pp. 3549-3558, 1999.
9. E. Ferrero, P. Biswas, K. Vettoretto et al. , "Macrophages exposed to Mycobacterium tuberculosis release chemokines able to recruit selected leucocyte subpopulations: focus on γδ cells," Immunology, vol. 108, no. 3, pp. 365-374, 2003.
10. N. N. Chegou, A. K. Detjen, L. Thiart et al. , "Utility of host markers detected in quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting," PLoSONE, vol. 8, no. 5, Article IDe64226, 2013.
11. J. Lighter, M. Rigaud, M. Huie, C.-H. Peng, and H. Pollack, "Chemokine IP-10: an adjunct marker for latent tuberculosis infection in children," International Journal of Tuberculosis and Lung Disease, vol. 13, no. 6, pp. 731-736, 2009.
12. E. Whittaker, A. Gordon, and B. Kampmann, "Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma?"PLoS ONE, vol. 3, no. 12, Article IDe3901, 2008.
13. A. Azzurri, O. Y. Sow, A. Amedei et al. , "IFN-γ-inducible protein 10 and pentraxin 3 plasma levels are tools formonitoring inflammation and disease activity in Mycobacterium tuberculosis infection," Microbes and Infection, vol. 7, no. 1, pp. 1-8, 2005.
14. M. Ruhwald, J. Petersen, K. Kofoed et al. , "Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10," PLoS ONE, vol. 3, no. 8, Article ID e2858, 2008.
15. D. Goletti, A. Sanduzzi, and G. Delogu, "Performance of the tuberculin skin test and interferon-g release assays: an update on the accuracy, cutoff stratification, and new potential immune-based approaches,"The Journal of Rheumatology, vol. 41, no. 91, pp. 24-31, 2014.
16. B. S. A. Kabeer, A. Raja, B. Raman et al. , "IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy," BMC Infectious Diseases, vol. 11, article 135, 2011.
17. A. Cannas, L. Calvo, T. Chiacchio et al. , "IP-10 detection in urine is associated with lung diseases," BMC Infectious Diseases, vol. 10, article 333, 2010.
18. WHO, Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children, World Health Organization, Geneva, Switzerland, 2014.
19. C. A. Wright, A. C. Hesseling, C. Bamford, S. M. Burgess, R. Warren, and B. J. Marais, "Fine-needle aspiration biopsy: a firstline diagnostic procedure in paediatric tuberculosis suspects with peripheral lymphadenopathy?"The International Journal of Tuberculosis and Lung Disease, vol. 13, no. 11, pp. 1373-1379, 2009.
20. V. Vanini, E. Petruccioli, C. Gioia et al. , "IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country," Journal of Infection, vol. 65, no. 1, pp. 49-59, 2012.
21. L. Petrone, T. Chiacchio, V. Vanini et al. , "High urine IP-10 levels associate with chronic HCV infection," Journal of Infection, vol. 68, no. 6, pp. 591-600, 2014.
22. G. Maartens, C. Celum, and S. R. Lewin, "HIV infection: epidemiology, pathogenesis, treatment, and prevention," The Lancet, vol. 384, no. 9939, pp. 258-271, 2014.
23. M. Muenchhoff, A. J. Prendergast, and P. J. R. Goulder, "Immunity to HIV in early life," Frontiers in Immunology, vol. 5, article 391, 2014.
24. M. Liu, S. Guo, J. M. Hibbert et al. , "CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications," Cytokine and Growth Factor Reviews, vol. 22, no. 3, pp. 121-130, 2011.
25. L. A. Ramirez, T. A. Arango, E. Thompson, M. Naji, P. Tebas, and J. D. Boyer, "High IP-10 levels decrease T cell function inHIV-1-infected individuals on ART," Journal of Leukocyte Biology, vol. 96, no. 6, pp. 1055-1063, 2014.
26. A. Casrouge, J. Decalf, M. Ahloulay et al. , "Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV," The Journal of Clinical Investigation, vol. 121, no. 1, pp. 308-317, 2011.
27. S. Sollai, L. Galli, M. de Martino, and E. Chiappini, "Systematic review and meta-analysis on the utility of Interferon-gamma release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a 2013 update," BMC Infectious Diseases, vol. 14, supplement 1, article S6, 2014.
28. M. Sester, F. van Leth, J. Bruchfeld et al. , "Risk assessment of tuberculosis in immunocompromised patients. A TBNET study," The American Journal of Respiratory and Critical Care Medicine, vol. 190, no. 10, pp. 1168-1176, 2014.
29. D. Goletti, S. Carrara, H. Mayanja-Kizza et al. , "Response to M. tuberculosis selected RD1 peptides in ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study," BMC Infectious Diseases, vol. 8, article 11, 2008.
30. P. H. Lagrange, S. K. Thangaraj, R. Dayal et al. , "A toolbox for tuberculosis (TB) diagnosis: an Indian multicentric study (2006-2008). Evaluation of QuantiFERON-TB gold in tube for TB diagnosis," PLoS ONE, vol. 8, no. 9, Article ID e73579, 2013.
31. H. Xia, X. Wang, F. Li et al. , "Diagnostic values of the Quanti FERON-TB Gold In-tube assay carried out in China for diagnosing pulmonary tuberculosis," PLOS ONE, vol. 10, no. 4, Article ID e0121021, 2015.